Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 401-990-0 | CAS number: 106990-43-6 CHIMASSORB 119; LOWILITE 19
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicological Summary
- Administrative data
- Workers - Hazard via inhalation route
- Workers - Hazard via dermal route
- Workers - Hazard for the eyes
- Additional information - workers
- General Population - Hazard via inhalation route
- General Population - Hazard via dermal route
- General Population - Hazard via oral route
- General Population - Hazard for the eyes
- Additional information - General Population
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 1.14 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- other: ECHA REACH Guidance and ECETOC Guidelines
- Overall assessment factor (AF):
- 15
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 17.1 mg/m³
- Explanation for the modification of the dose descriptor starting point:
- Only oral repeated toxicity studies are available for HALS 11.
- AF for dose response relationship:
- 1
- Justification:
- The starting point for the DNEL calculation was a NOAEL, therefore the default assessment factor, as a standard procedure, is 1.
- AF for differences in duration of exposure:
- 2
- Justification:
- An assessment factor of 2 has been applied in order to consider the differences in the duration of the exposure between the oral 90-day repeated toxicity study and a chronic exposure.
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- Allometric scaling does not apply in case of oral-inhalation route to route extrapolation.
- AF for other interspecies differences:
- 2.5
- Justification:
- No substance-specific data are available, so a default assessment factor of 2.5 has been applied for other interspecies differences.
- AF for intraspecies differences:
- 3
- Justification:
- An assessment factor of 3 has been chosen to cover workers, as this population does not cover the very young, the very old, and the very ill.
- AF for the quality of the whole database:
- 1
- Justification:
- Data regarding HALS 11 are complete and of good quality, indeed, where no specific studies regarding the substance are available, data regarding the similar substance Uvasorb HA88 cover all the data gaps.
- AF for remaining uncertainties:
- 1
- Justification:
- No remaining uncertainties are foreseen. Assessment factors have been set according to ECHA and ECETOC guidelines (ECHA, 2010. Guidance on information requirements and chemical safety assessment. Chapter R.8: Characterization of dose (concentration)-response for human health; ECETOC, 2010. Guidance on Assessment Factors to Derive a DNEL. Technical Report No. 110).
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.16 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- other: ECHA REACH Guidelines and ECETOC Guidelines
- Overall assessment factor (AF):
- 60
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 9.7 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
- Only oral repeated toxicity studies are available for HALS 11.
- AF for dose response relationship:
- 1
- Justification:
- The starting point for the DNEL calculation was a NOAEL, therefore the default assessment factor, as a standard procedure, is 1.
- AF for differences in duration of exposure:
- 2
- Justification:
- An assessment factor of 2 has been applied in order to consider the differences in the duration of the exposure between the oral 90-day repeated toxicity study and a chronic exposure.
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- Allometric scaling is not appropriate, because HALS 11 is not renally excreted (n rats only 0.28 – 0.6% of the administered dose).
- AF for other interspecies differences:
- 10
- Justification:
- The 96-99% of the substance is excreted via feces, mainly because, considering its bio-physico-chemical characteristics (molecular weight, solubility, biodegradation), it will be poorly absorbed by skin (European Commission, Health and Consumer Protection Directorate, 2004. Guidance Document on Dermal Absorption. Sanco/222/2000 rev.7) and by the gastrointestinal tract (Milman and Weisburger, 1994. Handbook of Carcinogen Testing. William Andrew. 856 pages). The absorbed amount, moreover, will probably be excreted via bile, on the basis of the observations in liver in the 90-day study (mottled liver and increase of organ weight). Differences in biliary excretion between species (i.e. rats and humans) depend also by liver weight and transport proteins on hepatocytes. Studies demonstrated that this way of excretion is much more efficient in rats than in humans, hence humans should be considered, in the absence of specific data, more sensitive than laboratory animals (Yurong Lai, 2009. Identification of interspecies difference in hepatobiliary transporters to improve extrapolation of human biliary secretion. Expert Opin.Drug Metab. Toxicol., 5(10), 1175-1187). Considering available data and the worst case assumption, an A.F. of 10 has been considered conservative enough to protect human population.
- AF for intraspecies differences:
- 3
- Justification:
- An assessment factor of 3 has been chosen to cover workers, as this population does not cover the very young, the very old, and the very ill.
- AF for the quality of the whole database:
- 1
- Justification:
- Data regarding HALS 11 are complete and of good quality, indeed, where no specific studies regarding the substance are available, data regarding the similar substance Uvasorb HA88 cover all the data gaps.
- AF for remaining uncertainties:
- 1
- Justification:
- No remaining uncertainties are foreseen. Assessment factors have been set according to ECHA and ECETOC guidelines (ECHA, 2010. Guidance on information requirements and chemical safety assessment. Chapter R.8: Characterization of dose (concentration)-response for human health; ECETOC, 2010. Guidance on Assessment Factors to Derive a DNEL. Technical Report No. 110).
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- high hazard (no threshold derived)
- Most sensitive endpoint:
- sensitisation (skin)
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - workers
Two DNEL values were derived for systemic effects after long-term exposure in workers: a dermal DNEL and an inhalation DNEL. Both values were obtained from the NOAEL of the 90-day repeated toxicity study: 9.7 mg/kg bw/day. As this NOAEL was observed in an oral study, a route-to-route extrapolation was needed in order to obtain the correct starting points for the derivation of the DNELs. The correct starting points were than divided by an overall assessment factor, which was a result of various consideration on uncertainties in inter-and intra-species variations, and on differences in the duration of exposure between test animals and humans. Moreover also the whole quality of the database was considered.
For acute local effects no DNEL has be derived, as the substance is considered of no concern for this endpoint and because the long-term DNEL are considered protective enough to prevent also acute exposure effects.
A qualitative approach has been chosen for the sensitization endpoint, as the substance is classified as a strong skin sensitizer.General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.34 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- other: ECHA REACH Guidelines and ECETOC Guidelines
- Overall assessment factor (AF):
- 25
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 8.43 mg/m³
- Explanation for the modification of the dose descriptor starting point:
- Only an oral 90-day repeated toxicity study is available for HALS 11.
- AF for dose response relationship:
- 1
- Justification:
- The starting point for the DNEL calculation was a NOAEL, therefore the default assessment factor, as a standard procedure, is 1.
- AF for differences in duration of exposure:
- 2
- Justification:
- An assessment factor of 2 has been applied in order to consider the differences in the duration of the exposure between the oral 90-day repeated toxicity study and a chronic exposure.
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- Allometric scaling does not apply in case of oral-inhalation route to route extrapolation.
- AF for other interspecies differences:
- 2.5
- Justification:
- No substance-specific data are available, so a default assessment factor of 2.5 has been applied for other interspecies differences.
- AF for intraspecies differences:
- 5
- Justification:
- An assessment factor of 5 has been chosen to cover general population, as this population includes also the very young, the very old, and the very ill.
- AF for the quality of the whole database:
- 1
- Justification:
- Data regarding HALS 11 are complete and of good quality, indeed, where no specific studies regarding the substance are available, data regarding the similar substance Uvasorb HA88 cover all the data gaps.
- AF for remaining uncertainties:
- 1
- Justification:
- No remaining uncertainties are foreseen. Assessment factors have been set according to ECHA and ECETOC guidelines (ECHA, 2010. Guidance on information requirements and chemical safety assessment. Chapter R.8: Characterization of dose (concentration)-response for human health; ECETOC, 2010. Guidance on Assessment Factors to Derive a DNEL. Technical Report No. 110).
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - General Population
An inhalation DNEL value was derived for systemic effects after long-term exposure in general population. The value was obtained from the NOAEL of the 90-day repeated toxicity study: 9.7 mg/kg bw/day. As this NOAEL was observed in an oral study, a route-to-route extrapolation was needed in order to obtain the correct starting point for the derivation of the DNEL. The correct starting point was than divided by an overall assessment factor, which was a result of various consideration on uncertainties in inter-and intra-species variations, and on differences in the duration of exposure between test animals and humans. Moreover also the whole quality of the database was considered.No assessment for the other end-points like acute exposure effects or sensitizing effects was deemed necessary for general population, as the exposure to substance is not likely to occur. Further details on exposure patterns are available in the relative section of the report.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.